It is a healthcare private limited company based in Thane, Maharashtra, India, established in 1999.
1999 | Thane, Maharashtra, India | Under LiquidationHargo Pharm Private Limited, a under liquidation private limited company, was established on 05 March 1999 in Thane, Maharashtra, India. Engaging in other hospital and medical care activities within the healthcare sector, it holds CIN: U24239MH1999PTC118676. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹7.50 Cr and a paid-up capital of ₹7.50 Cr.
Its leadership includes Harish Kumar (Director), Gopal Rambilas Singh (Director). Past directors included Vilhas Shankar Jadhhav, Ajaai Pratap Singh, Sanjeev Kumar Bhagat. It holds ₹15.00 Cr open charges and ₹11.45 Cr settled loans. Its latest AGM occurred on 30 September 2017, with the balance sheet filed on 31 March 2017. It is based at 4, Laxmi Park, Kalher, Bhiwandi,, Thane, Maharashtra, 421302.
U24239MH1999PTC118676
118676
05 March 1999
₹7.50 Cr
₹7.50 Cr
Roc Mumbai
Unlisted
Under Liquidation
Explore comprehensive insights into Hargo Pharm Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harish Kumar | Director | 15 Nov 2011 | Current |
| Gopal Rambilas Singh | Director | 30 Sep 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Dec 2011 | Past |
| Pramod Abcsdd | Director | 24 Feb 2009 | Past |
| Pramod Abcsdd | Director | 25 Aug 2007 | Past |
| Pramod Abcsdd | Manager | 16 Jul 2009 | Past |
| Pramod Abcsdd | Director | 21 Jan 2013 | Past |
| Pramod Abcsdd | Director | 16 Feb 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Hargo Pharm's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Hargo Pharm had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹150,000,000.00
₹114,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Aug 2006 | Canara Bank | ₹10.50 Cr | Open |
| 31 Mar 2006 | Canara Bank | ₹4.50 Cr | Open |
| 12 Dec 2008 | Edelweiss Asset Reconstruction Company Limited | ₹7.50 Cr | Satisfied |
| 04 Jul 2008 | Axis Bank Limited | ₹3.95 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Hargo Pharm, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hargo Pharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hargo Pharm's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 12 Dec 2008 via Charge ID 10136901 with Edelweiss Asset Reconstruction Company Limited was fully satisfied on 03 May 2018. was recorded as a recent event.
Hargo Pharm Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records. was recorded as a recent event.
Progress on Hargo Pharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Mumbai. was documented.
Progress on A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 7.50 Cr registered on 12 Dec 2008 with Charge ID 10136901 was modified on 22 May 2014. was documented.
Progress on Harish Kumar was appointed as a Director was appointed as a Director on 15 Nov 2011 & has been associated with this company since 14 years 16 days . was documented.
The activity Gopal Rambilas Singh was appointed as a Director was appointed as a Director on 30 Sep 2011 & has been associated with this company since 14 years 2 months . was completed.
The CIN of Hargo Pharm Private Limited is U24239MH1999PTC118676.
Hargo Pharm Private Limited is headquartered at 4, Laxmi Park, Kalher, Bhiwandi,, Thane, Maharashtra, 421302.
Hargo Pharm Private Limited was incorporated on 05 March 1999.
The current directors of Hargo Pharm Private Limited are
The primary industry of Hargo Pharm Private Limited is Healthcare.
Hargo Pharm Private Limited is unlisted.
The authorized capital of Hargo Pharm Private Limited is ₹7.50 Cr, and the paid-up capital is ₹7.50 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX